Increased platelet and erythrocyte arginase activity in chronic obstructive pulmonary disease associated with tobacco or wood smoke exposure

Journal of Investigative Medicine

Volumn 59, Issue 3, 2011, Pages 587-592

  Guzmán Grenfell, Alberto ^a   Nieto Velázquez, Nayeli ^a   Torres Ramos, Yessica ^a   Montoya Estrada, Araceli ^a   Ramírez Venegas, Alejandra ^b   Ochoa Cautino, Leticia ^b   Flores Trujillo, Fernando ^b   Hicks, Juan José ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Arginase; COPD; Erythrocytes; Oxidative stress; Platelets; Tobacco and wood smoke

Indexed keywords

ARGINASE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; THROMBOCYTE ENZYME; TOBACCO SMOKE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; WOOD SMOKE;

AGED; ARTICLE; BLOOD LEVEL; CELL LYSATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ERYTHROCYTE; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; MALE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; THROMBOCYTE;

NICOTIANA TABACUM;

AGED; AGED, 80 AND OVER; ARGINASE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; ENZYME ACTIVATION; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; SMOKING; WOOD;

EID: 79960091089     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31820bf475     Document Type: Article

References (35)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176: 532-555. (Pubitemid 47403272)
2. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56:515-548. (Pubitemid 39658462)
3. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Rev Pathol. 2009;4:435-459.
4. Ramírez-Venegas A, Pérez-Padilla R, Rivera RM, et al. Other causes of chronic obstructive pulmonary disease: exposure to biofuel smoke. Hot Topics Resp Med. 2007;4:7-13.
5. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 2009;6:527-531.
6. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:171-184.
7. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Biochem Physiol B Biochem Mol Biol. 1996;114: 107-132. (Pubitemid 26234050)
8. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906-911. (Pubitemid 47083958)
9. Satriano J. Arginine pathways and the inflammatory response: inter regulation of nitric oxide and polyamines: review article. Amino Acids. 2004;26:321-329. (Pubitemid 39093134)
10. Martin JF, Slater DN, Trowbridge EA. Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease. Lancet. 1983;1:793-796. (Pubitemid 13116506)
11. Pitchford SC, Yano H, Lever R, et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol. 2003;112:109-118. (Pubitemid 36819815)
12. Ulfman LH, Joosten DP, Van Aalst CW, et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol Biol. 2003;28:512-519. (Pubitemid 36399374)
13. Pitchford SC, Riffo-Vasquez Y, Sousa A, et al. Platelets are necessary for airwall remodeling in a murine model of chronic allergic inflammation. Blood. 2004;103:639-647. (Pubitemid 38140099)
14. Davi G, Basili S, Vieri M, et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am J Crit Care Med. 1997;156:1794-1799. (Pubitemid 28011784)
15. Ferroni P, Basili S, Martini F, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investing Med. 2000;48:21-27. (Pubitemid 30485618)
16. Takajo Y, Ikeda H, Haramaki N, et al. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol. 2001;38:1320-1327. (Pubitemid 33033005)
17. Fimognari FL, Scarlata S, Conte ME, et al. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:89-96. (Pubitemid 351523720)
18. Villanueva VR, Giret M. Human platelet arginase. Mol Cell Biochem. 1980 33:97-100. (Pubitemid 11101263)
19. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelet regulates aggregation. Proc Natl Acad Sci U S A. 1990;87:5193-5197.
20. Lucantoni G, Pietraforte D, Matarrese P, et al. The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. Antioxid Redox Signal. 2006;8:1171-1182. (Pubitemid 44182416)
21. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. (Pubitemid 41079078)
22. Pérez-Padilla R, Valdivia G, Muiño A, et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over [in Spanish]. Arch Bronconeumol. 2006;42:317-325. (Pubitemid 44213733)
23. Corraliza IM, Campo ML, Modolell M. Determination of arginase in macrophages: a micromethod. J Immunological Methods. 1994;174:231-235.
24. Dalle-Done I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23-38. (Pubitemid 36187411)
25. Gérard-Monnier D, Erdelmeir I, Régnard K, et al. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4 hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998;11:1176-1183. (Pubitemid 28500798)
26. Miranda KM, Espey MG,Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62-71. (Pubitemid 34146173)
27. Torres-Ramos YD, Guzman-Grenfell AM, Montoya-Estrada A, et al. RBC membrane damage and decreased band 3 phospho-tyrosine phosphatase activity are markers of COPD progression. Front Biosci (Elite Ed). 2010;2:1385-1393.
28. Zhang WZ, Venardos K, Chinn-Dusting J, et al. Adverse effects of cigarette smoke on NO bioavailability. Role of arginine metabolism and oxidative stress. Hypertension. 2006;48:278-285. (Pubitemid 44309824)
29. Imamura M, Waseda Y, Marinova GV, et al. Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract. Am J Physiol Regul Integr Comp Physiol. 2007;293:R2081YR2089.
30. Morris CR, Poljakovic M, Lavrisha L, et al. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med. 2004;170:148-153. (Pubitemid 38925160)
31. Maarsingh H, Bossenga BE, Bos IS, et al. L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur Respir J. 2009;34:191-199.
32. Raghavachari N, Xu X, Harris A, et al. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation. 2007;115:1551-1562. (Pubitemid 46648640)
33. Morris CR, Gladwin MT, Kato GJ. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med. 2008;8:620-632.
34. Irwin C, Roberts W, Naseem KM. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation. Platelets. 2009;15:1-9.
35. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714.